Definition of joint biomarker signatures for patients with locally advanced HNSCC treated by postoperative radiochemotherapy – A multicentre study of the DKTK-ROG.
Several prognostic biomarkers have previously been identified for patients with locally advanced head and neck squamous cell carcinoma (HNSCC) treated with postoperative radiochemotherapy (PORT-C) in a comprehensive biomarker program conducted by the German Cancer Consortium - Radiation Oncology Group (DKTK-ROG). Here, we combined these biomarkers into composite signatures for loco-regional control (LRC) and overall survival (OS) in 143 patients with HPV16 DNA-negative tumours. The C-indices for baseline, extended and data-driven signatures were 0.77, 0.93 and 0.94 for LRC and 0.69, 0.83 and 0.82 for OS, respectively. These predefined models will next be tested in the prospective HNprädBio validation cohort, which has completed recruitment and data collection.